Variables | DSS | OS | ||||||
---|---|---|---|---|---|---|---|---|
P-value | HR | 95.0% Exp(B) CI | P-value | HR | 95.0% Exp(B) CI | |||
lower | upper | lower | upper | |||||
Age (years) | ||||||||
< 65 | Reference | —— | Reference | —— | ||||
≥ 65 | .006 | 2.116 | 1.243 | 3.603 | .000 | 4.033 | 2.762 | 5.888 |
Race | .287 | .690 | ||||||
White | Reference | —— | Reference | —— | ||||
Black | .119 | .462 | .175 | 1.220 | .874 | 1.045 | .607 | 1.799 |
Other | .934 | 1.033 | .482 | 2.215 | .390 | 1.235 | .764 | 1.996 |
Marital status | .853 | .058 | ||||||
Not married | Reference | —— | Reference | —— | ||||
Married | .757 | 1.123 | .540 | 2.334 | .029 | 1.849 | 1.066 | 3.208 |
Unkonw | .788 | .838 | .232 | 3.027 | .702 | 1.195 | .479 | 2.981 |
Year of diagnosis | .029 | .158 | ||||||
2001–2005 | Reference | —— | Reference | —— | ||||
2006–2010 | .008 | 4.624 | 1.498 | 14.278 | .026 | 2.214 | 1.101 | 4.452 |
2011–2015 | .007 | 6.761 | 1.672 | 27.341 | .075 | 2.238 | .923 | 5.427 |
2016–2019 | .084 | 3.706 | .840 | 16.354 | .192 | 1.907 | .723 | 5.033 |
Primary site | .157 | .432 | ||||||
Nipple | Reference | —— | Reference | —— | ||||
Central portion | .993 | .635 | .000 | 4.749E + 44 | .900 | 477.401 | .000 | 2.847E + 44 |
Inner quadrant | .921 | 172.441 | .000 | 4.153E + 46 | .889 | 926.757 | .000 | 5.502E + 44 |
Lower-inner quadrant | .922 | 167.893 | .000 | 4.050E + 46 | .894 | 706.937 | .000 | 4.203E + 44 |
Upper-outer quadrant | .922 | 169.359 | .000 | 4.074E + 46 | .887 | 1099.677 | .000 | 6.526E + 44 |
Lower-outer quadrant | .912 | 327.782 | .000 | 7.890E + 46 | .881 | 1582.618 | .000 | 9.398E + 44 |
Axillary tail | .869 | 5453.511 | .000 | 1.347E + 48 | .866 | 3900.965 | .000 | 2.369E + 45 |
Overlapping lesion | .923 | 152.386 | .000 | 3.668E + 46 | .889 | 943.993 | .000 | 5.603E + 44 |
NA | .925 | 138.849 | .000 | 3.344E + 46 | .889 | 962.276 | .000 | 5.712E + 44 |
Histologic type | .000 | .000 | ||||||
HR-/HER2- | Reference | —— | Reference | —— | ||||
HR-/HER2+ | .036 | .177 | .035 | .891 | .041 | .294 | .091 | .951 |
HR+/HER2- | .000 | .132 | .057 | .306 | .000 | .214 | .112 | .408 |
HR+/HER2+ | .000 | .134 | .046 | .392 | .001 | .270 | .125 | .582 |
NA | .038 | .287 | .088 | .933 | .000 | .227 | .103 | .500 |
Stage | .000 | .000 | ||||||
I | Reference | —— | Reference | —— | ||||
II | .002 | 4.317 | 1.701 | 10.957 | .197 | 1.303 | .872 | 1.946 |
III | .000 | 13.808 | 5.114 | 37.281 | .000 | 3.145 | 1.909 | 5.182 |
IV | .000 | 51.387 | 17.045 | 154.918 | .000 | 3.931 | 1.953 | 7.913 |
NA | .028 | 7.239 | 1.236 | 42.391 | .163 | 2.126 | .737 | 6.126 |
Surgery approach | .004 | .000 | ||||||
No surgery | Reference | —— | Reference | —— | ||||
BCS | .001 | .219 | .086 | .558 | .000 | .261 | .146 | .465 |
Mastectomy | .007 | .300 | .126 | .714 | .000 | .238 | .137 | .414 |
NA | .023 | .017 | .001 | .574 | .071 | .061 | .003 | 1.270 |
Radiation status | ||||||||
No | Reference | —— | Reference | —— | ||||
Yes | .046 | .566 | .323 | .991 | .006 | .589 | .404 | .859 |
Chemotherapy status | ||||||||
No | Reference | —— | Reference | —— | ||||
Yes | .972 | .989 | .550 | 1.780 | .305 | .804 | .530 | 1.220 |